Codiak BioSciences, Inc. Deferred Tax Assets, Net of Valuation Allowance
Codiak BioSciences, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $9.17 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-03-10
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.17M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.53M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.90M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2021-12-31 | $9.17M 10-K · filed 2022-03-10 |
| 2020-12-31 | $9.53M 10-K · filed 2022-03-10 |
| 2019-12-31 | $1.90M 10-K · filed 2021-03-17 |